<VariationArchive VariationID="438330" VariationName="NM_000527.5(LDLR):c.2407_2424del (p.Cys803_Leu808del)" VariationType="Deletion" Accession="VCV000438330" Version="6" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2017-09-11" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="431960" VariationID="438330">
      <GeneList>
        <Gene Symbol="LDLR" FullName="low density lipoprotein receptor" GeneID="3949" HGNC_ID="HGNC:6547" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11089463" stop="11133820" display_start="11089463" display_stop="11133820" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11200037" stop="11244505" display_start="11200037" display_stop="11244505" Strand="+" />
          </Location>
          <OMIM>606945</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LDLR">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LDLR">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000527.5(LDLR):c.2407_2424del (p.Cys803_Leu808del)</Name>
      <CanonicalSPDI>NC_000019.10:11129520:GTCTTCCTTTGCCTGGGGGTCTTCCTT:GTCTTCCTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11129521" stop="11129538" display_start="11129521" display_stop="11129538" variantLength="18" positionVCF="11129520" referenceAlleleVCF="CGTCTTCCTTTGCCTGGGG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11240197" stop="11240214" display_start="11240197" display_stop="11240214" variantLength="18" positionVCF="11240196" referenceAlleleVCF="CGTCTTCCTTTGCCTGGGG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.11129530_11129547del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.11129530_11129547del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.11240206_11240223del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.11240206_11240223del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009060.1" sequenceAccession="NG_009060" sequenceVersion="1" change="g.45150_45167del">
            <Expression>NG_009060.1:g.45150_45167del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000527.5" sequenceAccession="NM_000527" sequenceVersion="5" change="c.2407_2424del" MANESelect="true">
            <Expression>NM_000527.5:c.2407_2424del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000518.1" sequenceAccession="NP_000518" sequenceVersion="1" change="p.Cys803_Leu808del">
            <Expression>NP_000518.1:p.Cys803_Leu808del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195798.2" sequenceAccession="NM_001195798" sequenceVersion="2" change="c.2407_2424del">
            <Expression>NM_001195798.2:c.2407_2424del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182727.1" sequenceAccession="NP_001182727" sequenceVersion="1" change="p.Cys803_Leu808del">
            <Expression>NP_001182727.1:p.Cys803_Leu808del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195799.2" sequenceAccession="NM_001195799" sequenceVersion="2" change="c.2284_2301del">
            <Expression>NM_001195799.2:c.2284_2301del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182728.1" sequenceAccession="NP_001182728" sequenceVersion="1" change="p.Cys762_Leu767del">
            <Expression>NP_001182728.1:p.Cys762_Leu767del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195800.2" sequenceAccession="NM_001195800" sequenceVersion="2" change="c.1903_1920del">
            <Expression>NM_001195800.2:c.1903_1920del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182729.1" sequenceAccession="NP_001182729" sequenceVersion="1" change="p.Cys635_Leu640del">
            <Expression>NP_001182729.1:p.Cys635_Leu640del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001195803.2" sequenceAccession="NM_001195803" sequenceVersion="2" change="c.1873_1890del">
            <Expression>NM_001195803.2:c.1873_1890del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001182732.1" sequenceAccession="NP_001182732" sequenceVersion="1" change="p.Cys625_Leu630del">
            <Expression>NP_001182732.1:p.Cys625_Leu630del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_274" sequenceAccession="LRG_274">
            <Expression>LRG_274:g.45150_45167del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_274t1" sequenceAccession="LRG_274t1">
            <Expression>LRG_274t1:c.2407_2424del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_274p1" sequenceAccession="LRG_274p1" change="p.Cys803_Leu808del">
            <Expression>LRG_274p1:p.Cys803_Leu808del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000527.4" sequenceAccession="NM_000527" sequenceVersion="4" change="c.2407_2424delTGCCTGGGGGTCTTCCTT">
            <Expression>NM_000527.4:c.2407_2424delTGCCTGGGGGTCTTCCTT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645509300" DB="ClinGen" />
        <XRef Type="rs" ID="879255201" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000527.5(LDLR):c.2407_2424del (p.Cys803_Leu808del) AND Hypercholesterolemia, familial, 1" Accession="RCV000505234" Version="9">
        <ClassifiedConditionList TraitSetID="7435">
          <ClassifiedCondition DB="MedGen" ID="C0745103">Hypercholesterolemia, familial, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2019-01-26" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.2407_2424del (p.Cys803_Leu808del) AND Cardiovascular phenotype" Accession="RCV003159636" Version="9">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-16" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.2407_2424del (p.Cys803_Leu808del) AND LDLR-related disorder" Accession="RCV003409715" Version="5">
        <ClassifiedConditionList TraitSetID="89300">
          <ClassifiedCondition>LDLR-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-22" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000527.5(LDLR):c.2407_2424del (p.Cys803_Leu808del) AND Familial hypercholesterolemia" Accession="RCV003581674" Version="1">
        <ClassifiedConditionList TraitSetID="10706">
          <ClassifiedCondition DB="MedGen" ID="C0020445">Familial hypercholesterolemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-13" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-09-11" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(3); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">15199436</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24918045</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26220972</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33740630</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(3); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2023-04-12">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10706" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16649" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial hypercholesterolemia</ElementValue>
                <XRef ID="Familial+Hypercholesterolemia/2746" DB="Genetic Alliance" />
                <XRef ID="MONDO:0005439" DB="MONDO" />
                <XRef ID="398036000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/CG71</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Identification and management of familial hypercholesterolaemia, 2008 [Updated: 4 October 2019]</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="PLoS Currents, 2011">
                <URL>http://knol.google.com/k/ren%C3%A9e-m-ned/cascade-screening-for-familial/70fnx9tmvdav/13?collectionId=28qm4w0q65e4w.50#</URL>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng238</URL>
                <CitationText>UK NICE Guideline NG238, Cardiovascular disease: risk assessment and reduction, including lipid modification, 2023</CitationText>
              </Citation>
              <XRef ID="C0020445" DB="MedGen" />
              <XRef ID="MONDO:0005439" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS143890" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7435" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15983" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, FAMILIAL, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="600946.0028" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LDL RECEPTOR DISORDER</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type IIa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPER-LOW-DENSITY-LIPOPROTEINEMIA</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIC XANTHOMATOSIS, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
                <XRef Type="MIM" ID="144400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fredrickson type IIa hyperlipoproteinemia</ElementValue>
                <XRef ID="397915002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyper-beta-lipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypercholesterolemia, familial, 1</ElementValue>
                <XRef ID="MONDO:0007750" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FH</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHC</ElementValue>
                <XRef Type="MIM" ID="143890" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/CG71</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Identification and management of familial hypercholesterolaemia, 2008 [Updated: 4 October 2019]</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="CSANZ, 2012">
                <ID Source="PubMed">22364837</ID>
              </Citation>
              <Citation Type="general" Abbrev="IPMFH, 2004">
                <ID Source="PubMed">15177124</ID>
              </Citation>
              <Citation Type="general" Abbrev="NLAEP, 2011">
                <ID Source="PubMed">21600525</ID>
              </Citation>
              <Citation Type="general" Abbrev="Int'l FH Foundation, 2014">
                <ID Source="PubMed">24418289</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="general" Abbrev="Feldman et al., 2015">
                <ID Source="PubMed">25404096</ID>
              </Citation>
              <Citation Type="general" Abbrev="EAS, 2014">
                <ID Source="PubMed">25053660</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLEF, 2014">
                <ID Source="PubMed">24636176</ID>
              </Citation>
              <Citation Type="general" Abbrev="PLEF, 2013">
                <ID Source="PubMed">23725921</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="391665" DB="Orphanet" />
              <XRef ID="C0745103" DB="MedGen" />
              <XRef ID="MONDO:0007750" DB="MONDO" />
              <XRef Type="MIM" ID="143890" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89300" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70661" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">LDLR-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LDLR-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1161837" SubmissionDate="2017-04-17" DateLastUpdated="2017-09-11" DateCreated="2017-09-11">
        <ClinVarSubmissionID localKey="g.45150_45167del" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000599417" DateUpdated="2017-09-11" DateCreated="2017-09-11" Type="SCV" Version="1" SubmitterName="Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge" OrgID="505909" OrganizationCategory="laboratory" OrgAbbreviation="INSA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <CellLine>HepG2 cells</CellLine>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">Reduced amount of 160kDa form</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">26220972</ID>
            </Citation>
            <Comment Type="public">Assay Description:Heterologous cells (HepG2), WB and imunoprecipitation assays</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000527.4:c.2407_2424del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NG_009060.1:g.45150_45167del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2584530</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2829090" SubmissionDate="2020-09-16" DateLastUpdated="2020-09-19" DateCreated="2020-09-19">
        <ClinVarSubmissionID localKey="NM_000527.4:c.2407_2424delTGCCTGGGGGTCTTCCTT" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001432637" DateUpdated="2020-09-19" DateCreated="2020-09-19" Type="SCV" Version="1" SubmitterName="Brunham Lab, Centre for Heart and Lung Innovation, University of British Columbia" OrgID="507262" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>MiSeq</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Citation>
                <ID Source="PubMed">31345425</ID>
              </Citation>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">180426_M04829_0030_000000000-BPB78:FH002220000_S45:131</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="1998-05-14" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Dutch Lipid Clinic Network Criteria score</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">low-density lipoprotein cholesterol level</ElementValue>
                </Name>
              </Trait>
              <Comment>8 (clinical Dutch Lipid Clinic Network Criteria score); 6.09 mmol/L (calculated low-density lipoprotein cholesterol level)</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.2407_2424delTGCCTGGGGGTCTTCCTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143890" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8149309</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7691957" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="35266132|LDLR-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004112251" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The LDLR c.2407_2424del18 variant is predicted to result in an in-frame deletion (p.Cys803_Leu808del). This variant has been reported in the heterozygous state in four individuals with hypercholesterolemia (Leren et al. 2021. PubMed ID: 33740630. Table S1). In vitro functional analysis suggests that this deletion may reduce protein level (Strøm et al. 2015. PubMed ID: 26220972). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.2407_2424del18</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LDLR-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983530" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4953481|MedGen:C0020445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297885" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">33740630</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26220972</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15199436</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24918045</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33740630</ID>
          </Citation>
          <Comment>This variant, c.2407_2424del, results in the deletion of 6 amino acid(s) of the LDLR protein (p.Cys803_Leu808del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with familial hypercholesterolemia (PMID: 33740630). ClinVar contains an entry for this variant (Variation ID: 438330). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects LDLR function (PMID: 26220972). This variant disrupts a region of the LDLR protein in which other variant(s) (p.Gly805Arg) have been determined to be pathogenic (PMID: 15199436, 24918045, 33740630). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.11240197_11240214del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7256506" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-04-15">
        <ClinVarSubmissionID localKey="a133502|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003912559" DateUpdated="2024-05-01" DateCreated="2023-04-15" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26220972</ID>
          </Citation>
          <Comment>The c.2407_2424del18 variant (also known as p.C803_L808del) is located in coding exon 17 of the LDLR gene. This variant results from an in-frame TGCCTGGGGGTCTTCCTT deletion at nucleotide positions 2407 to 2424. This results in the in-frame deletion of the amino acids at codons 803 to 808. An in vitro assay showed this alteration may impact protein function (Str&amp;oslash;m TB et al. Hum Mol Genet, 2015 Oct;24:5836-44). This amino acid region is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000527.4:c.2407_2424del18</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2829090" TraitType="Finding" MappingType="Name" MappingValue="low-density lipoprotein cholesterol level" MappingRef="Preferred">
        <MedGen CUI="None" Name="low-density lipoprotein cholesterol level" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7256506" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7983530" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2829090" TraitType="Finding" MappingType="Name" MappingValue="Dutch Lipid Clinic Network Criteria score" MappingRef="Preferred">
        <MedGen CUI="None" Name="Dutch Lipid Clinic Network Criteria score" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1161837" TraitType="Disease" MappingType="XRef" MappingValue="C0020445" MappingRef="MedGen">
        <MedGen CUI="C0020445" Name="Familial hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7691957" TraitType="Disease" MappingType="Name" MappingValue="LDLR-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="LDLR-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2829090" TraitType="Disease" MappingType="XRef" MappingValue="143890" MappingRef="OMIM">
        <MedGen CUI="C0745103" Name="Hypercholesterolemia, familial, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

